Poly(ethylene glycol)-avidin bioconjugates: Suitable candidates for tumor pretargeting

Paolo Caliceti, Marco Chinol, Marta Roldo, Francesco M. Veronese, Alessandra Semenzato, Stefano Salmaso, Giovanni Paganelli

Research output: Contribution to journalArticle

Abstract

Avidin-poly(ethylene glycol) (PEG) conjugates were obtained by derivatization of about 10% of the protein amino groups (four amino groups per protein molecule) with linear 5 kDa PEG or branched 10 or 20 kDa PEGs. Circular dichroism analysis showed that the polymer conjugation neither altered the protein structure nor the environment of the aromatic amino acids which are present at the level of the biotin binding site. Spectroscopic studies were carried out to evaluate the biotin recognition activity of the conjugates either in terms of number of biotin binding sites or avidin/biotin affinity. Avidin-PEG 5 kDa and avidin-PEG 10 kDa displayed over 90% of the native protein biological activity while a reduction in the recognition of biotinylated antibodies of about 25% was found with PEG 20 kDa. In vivo studies demonstrated that the protein immunogenicity was in the order: wild type avidin>avidin-PEG 5 kDa>avidin-PEG 10 kDa>avidin-PEG 20 kDa. By intravenous injection into mice bearing a solid tumor, all conjugates displayed prolonged permanence in the circulation with respect to the native protein. The area under the curve values of avidin-PEG 5 kDa, avidin-PEG 10 kDa and avidin-PEG 20 kDa were about 3-, 7- and 30-times higher than the wild type avidin with reduced accumulation in kidneys and liver. Interestingly, all conjugates accumulated significantly in the tumor mass. In particular, in the case of avidin-PEG 20 kDa, 8% of the injected dose (ID)/g of tissue accumulated in the tumor after 5 h from the administration and over 6% of the ID/g was maintained throughout 72 h.

Original languageEnglish
Pages (from-to)97-108
Number of pages12
JournalJournal of Controlled Release
Volume83
Issue number1
DOIs
Publication statusPublished - Sep 18 2002

Fingerprint

Ethylene Glycol
Avidin
Neoplasms
Biotin
Proteins
Binding Sites
Aromatic Amino Acids
Circular Dichroism
Intravenous Injections
Area Under Curve
Polymers

Keywords

  • Avidin
  • Bioconjugates
  • Poly(ethylene glycol)
  • Pretargeting

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Poly(ethylene glycol)-avidin bioconjugates : Suitable candidates for tumor pretargeting. / Caliceti, Paolo; Chinol, Marco; Roldo, Marta; Veronese, Francesco M.; Semenzato, Alessandra; Salmaso, Stefano; Paganelli, Giovanni.

In: Journal of Controlled Release, Vol. 83, No. 1, 18.09.2002, p. 97-108.

Research output: Contribution to journalArticle

Caliceti, Paolo ; Chinol, Marco ; Roldo, Marta ; Veronese, Francesco M. ; Semenzato, Alessandra ; Salmaso, Stefano ; Paganelli, Giovanni. / Poly(ethylene glycol)-avidin bioconjugates : Suitable candidates for tumor pretargeting. In: Journal of Controlled Release. 2002 ; Vol. 83, No. 1. pp. 97-108.
@article{d6cc47d8883f43be99abcb269266f68a,
title = "Poly(ethylene glycol)-avidin bioconjugates: Suitable candidates for tumor pretargeting",
abstract = "Avidin-poly(ethylene glycol) (PEG) conjugates were obtained by derivatization of about 10{\%} of the protein amino groups (four amino groups per protein molecule) with linear 5 kDa PEG or branched 10 or 20 kDa PEGs. Circular dichroism analysis showed that the polymer conjugation neither altered the protein structure nor the environment of the aromatic amino acids which are present at the level of the biotin binding site. Spectroscopic studies were carried out to evaluate the biotin recognition activity of the conjugates either in terms of number of biotin binding sites or avidin/biotin affinity. Avidin-PEG 5 kDa and avidin-PEG 10 kDa displayed over 90{\%} of the native protein biological activity while a reduction in the recognition of biotinylated antibodies of about 25{\%} was found with PEG 20 kDa. In vivo studies demonstrated that the protein immunogenicity was in the order: wild type avidin>avidin-PEG 5 kDa>avidin-PEG 10 kDa>avidin-PEG 20 kDa. By intravenous injection into mice bearing a solid tumor, all conjugates displayed prolonged permanence in the circulation with respect to the native protein. The area under the curve values of avidin-PEG 5 kDa, avidin-PEG 10 kDa and avidin-PEG 20 kDa were about 3-, 7- and 30-times higher than the wild type avidin with reduced accumulation in kidneys and liver. Interestingly, all conjugates accumulated significantly in the tumor mass. In particular, in the case of avidin-PEG 20 kDa, 8{\%} of the injected dose (ID)/g of tissue accumulated in the tumor after 5 h from the administration and over 6{\%} of the ID/g was maintained throughout 72 h.",
keywords = "Avidin, Bioconjugates, Poly(ethylene glycol), Pretargeting",
author = "Paolo Caliceti and Marco Chinol and Marta Roldo and Veronese, {Francesco M.} and Alessandra Semenzato and Stefano Salmaso and Giovanni Paganelli",
year = "2002",
month = "9",
day = "18",
doi = "10.1016/S0168-3659(02)00199-2",
language = "English",
volume = "83",
pages = "97--108",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier B.V.",
number = "1",

}

TY - JOUR

T1 - Poly(ethylene glycol)-avidin bioconjugates

T2 - Suitable candidates for tumor pretargeting

AU - Caliceti, Paolo

AU - Chinol, Marco

AU - Roldo, Marta

AU - Veronese, Francesco M.

AU - Semenzato, Alessandra

AU - Salmaso, Stefano

AU - Paganelli, Giovanni

PY - 2002/9/18

Y1 - 2002/9/18

N2 - Avidin-poly(ethylene glycol) (PEG) conjugates were obtained by derivatization of about 10% of the protein amino groups (four amino groups per protein molecule) with linear 5 kDa PEG or branched 10 or 20 kDa PEGs. Circular dichroism analysis showed that the polymer conjugation neither altered the protein structure nor the environment of the aromatic amino acids which are present at the level of the biotin binding site. Spectroscopic studies were carried out to evaluate the biotin recognition activity of the conjugates either in terms of number of biotin binding sites or avidin/biotin affinity. Avidin-PEG 5 kDa and avidin-PEG 10 kDa displayed over 90% of the native protein biological activity while a reduction in the recognition of biotinylated antibodies of about 25% was found with PEG 20 kDa. In vivo studies demonstrated that the protein immunogenicity was in the order: wild type avidin>avidin-PEG 5 kDa>avidin-PEG 10 kDa>avidin-PEG 20 kDa. By intravenous injection into mice bearing a solid tumor, all conjugates displayed prolonged permanence in the circulation with respect to the native protein. The area under the curve values of avidin-PEG 5 kDa, avidin-PEG 10 kDa and avidin-PEG 20 kDa were about 3-, 7- and 30-times higher than the wild type avidin with reduced accumulation in kidneys and liver. Interestingly, all conjugates accumulated significantly in the tumor mass. In particular, in the case of avidin-PEG 20 kDa, 8% of the injected dose (ID)/g of tissue accumulated in the tumor after 5 h from the administration and over 6% of the ID/g was maintained throughout 72 h.

AB - Avidin-poly(ethylene glycol) (PEG) conjugates were obtained by derivatization of about 10% of the protein amino groups (four amino groups per protein molecule) with linear 5 kDa PEG or branched 10 or 20 kDa PEGs. Circular dichroism analysis showed that the polymer conjugation neither altered the protein structure nor the environment of the aromatic amino acids which are present at the level of the biotin binding site. Spectroscopic studies were carried out to evaluate the biotin recognition activity of the conjugates either in terms of number of biotin binding sites or avidin/biotin affinity. Avidin-PEG 5 kDa and avidin-PEG 10 kDa displayed over 90% of the native protein biological activity while a reduction in the recognition of biotinylated antibodies of about 25% was found with PEG 20 kDa. In vivo studies demonstrated that the protein immunogenicity was in the order: wild type avidin>avidin-PEG 5 kDa>avidin-PEG 10 kDa>avidin-PEG 20 kDa. By intravenous injection into mice bearing a solid tumor, all conjugates displayed prolonged permanence in the circulation with respect to the native protein. The area under the curve values of avidin-PEG 5 kDa, avidin-PEG 10 kDa and avidin-PEG 20 kDa were about 3-, 7- and 30-times higher than the wild type avidin with reduced accumulation in kidneys and liver. Interestingly, all conjugates accumulated significantly in the tumor mass. In particular, in the case of avidin-PEG 20 kDa, 8% of the injected dose (ID)/g of tissue accumulated in the tumor after 5 h from the administration and over 6% of the ID/g was maintained throughout 72 h.

KW - Avidin

KW - Bioconjugates

KW - Poly(ethylene glycol)

KW - Pretargeting

UR - http://www.scopus.com/inward/record.url?scp=0037130563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037130563&partnerID=8YFLogxK

U2 - 10.1016/S0168-3659(02)00199-2

DO - 10.1016/S0168-3659(02)00199-2

M3 - Article

C2 - 12220842

AN - SCOPUS:0037130563

VL - 83

SP - 97

EP - 108

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 1

ER -